Source link : https://newshealth.biz/health-news/one-drug-wins-and-another-fails-for-long-covid-fatigue/
Fluvoxamine and metformin have anti-inflammatory and immunomodulatory properties that have led researchers to test their ability to prevent and treat long COVID and its symptoms. In a randomized trial, fluvoxamine led to a significant reduction in fatigue as measured by the Fatigue Severity Scale compared with placebo at day 60, with a 99% posterior probability […]
The post One Drug Wins and Another Fails for Long COVID Fatigue first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-30 21:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8